Development

Joana S. Cristóvão, PhD, jscristovao@hovione.com, is an analytical scientist at Hovione Farmaciência S.A., R&D, Analytical Development.

Salomé Neto was a Master’s student at Hovione Farmaciência S.A., R&D, Analytical Development.

Articles

Establishing analytical workflows for complex biopharmaceutical molecules can help predict their risk of degradation.

Conformational and Colloidal Stability Studies to Predict the Best Biopharmaceutical Formulation

Syngene International appoints two US-based executives to senior level positions.

Syngene Announces Senior Level Appointments

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Advances in technology are accelerating the development and manufacture of subunit vaccines, an established class of vaccines.

Subunit Vaccines and the Fight Against COVID-19

Researchers from the Chalmers University of Technology and AstraZeneca have developed a new method of detecting and testing lipid nanoparticles.

Novel Automated Process May Speed Up Development of New Medicines

Editor of Pharmaceutical Technology Europe

Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.

Developing a Method for Success through Partnerships

Vaccine development is inherently challenging; however, in light of the COVID-19 pandemic, innovations have been prioritized, leading to accelerated development processes.

Overcoming Vaccine Development Challenges

DFE’s new line will offer market purity and low endotoxin excipients for use in formulation, while providing drug developers and manufacturers high-quality excipient technology and services. 

DFE Pharma to Launch New Biopharma Excipient Solution 

This new technology could eliminate the need for cold chain storage, transport, and distribution of temperature-sensitive molecules.

Hyalo Technologies Unveils Room Temperature Drug-Stabilizing Technology

A newly developed polymer, DynaShield, may have the capability to ensure global access for COVID-19 treatment and prevention.

Helena Offers Polymer Solution to Global Cold Chain Issues for COVID-19 Vaccines, Biologics, and Therapeutics

Evonik offers lipid nanoparticles for gene-based drug development and manufacturing. 